Diving deep into white matter to improve our understanding of the pathophysiology of schizophrenia

Will J. Cronenwett*, John G. Csernansky

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

4 Scopus citations
Original languageEnglish (US)
Pages (from-to)396-397
Number of pages2
JournalBiological psychiatry
Volume74
Issue number6
DOIs
StatePublished - Sep 15 2013

Funding

Dr. Cronenwett has received research funding from Novartis Inc., Sunovion Pharmaceuticals Inc., Otsuka Pharmaceuticals Inc., and Naurex Inc. Dr. Csernansky has received consulting fees for service on a data monitoring committee for Eli Lilly and Co.

ASJC Scopus subject areas

  • Biological Psychiatry

Cite this